Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Navigating commercial gaps to supercharge the UK life sciences sector

For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.

Latest news

Blackstone closes largest ever private funding investment round at $6.3bn

Blackstone says this is the largest private life sciences fund ever raised, which will fund innovation in pharma and medtech.

ACC 2026: Baxdrostat lowers BP in uncontrolled hypertension

At the 2026 ACC, researchers presented a meta-analysis of three trials (1,264 patients) assessing baxdrostat’s blood pressure and safety effects in uncontrolled hypertension.

ACC 2026: Lorundrostat lowers BP but raises hyperkalemia risk

At the 2026 ACC in New Orleans, Brazilian investigators presented a meta-analysis of three trials (1,060 patients) evaluating lorundrostat’s blood pressure-lowering effects and safety in uncontrolled hypertension.

uBriGene and Cellinfinity BIO collaborate to accelerate in vivo CAR-T therapies

The collaboration leverages uBriGene’s LVV Turbo platform for GMP lentiviral vector manufacturing and regulatory support.

Merck’s strategic shift: acquires Terns for $6.7bn, targeting dominance in CML

MSD’s acquisition of Terns Pharmaceuticals is a calculated, forward-looking manoeuvre to secure the next generation of haematology assets.

Teva receives FDA approval for Prolia biosimilar

The FDA approval for Ponlimsi is based on comprehensive evidence, including analytical and clinical data.